Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GERN · against 474 other Healthcare companies of similar size
Ranked #363 of 475 · scores higher than 22% of peers
Bars: peers in each 10-point band of the profitability score56 peers with a profitability score of 20–29, including GERN · Click a bar to see the companies
Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | GERN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 449 reported | -14.8% | 2.4% | 23% | 33% | |
| Operating marginHigher is better · 447 reported | -28.0% | 5.0% | 19% | 33% | |
| Return on assetsHigher is better · 469 reported | -13.0% | 1.0% | 22% | 33% | |
| Return on equityHigher is better · 449 reported | -28.3% | 1.5% | 21% | Context only | |
| Gross marginHigher is better · 494 reported | 58.5% | 42.6% | 69% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 363 | 2.8B CNY (≈$396M) | 24 | 29 | |
| 363 | 2.4B CNY (≈$331M) | 24 | 51 | |
| 363 | 775M USD | 24 | 31 | |
| 363 | 508M EUR (≈$559M) | 24 | 21 | |
| 363 | 598M USD | 24 | 49 | |
| 363 | 423M USD | 24 | 29 | |
| 363 | 513M USD | 24 | 31 | |
| 371 | 2.7B CNY (≈$381M) | 23 | 28 | |
| 371 | 6.0B CNY (≈$841M) | 23 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score